Inventor · disambiguated record
Makoto Tsuda
Also filed as: TSUDA MAKOTO
14 granted patents·9 pending applications·221 citations·filing 1986–2023
91Inventor score
Files withSQUARE ENIX CO LTD10ZAIDAN HOJIN BISEIBUTSU4NIPPON KAYAKU KK3NIPPON CHEMIPHAR CO2INOUE KAZUHIDE1
Top patents by PatentIndex Score
23 records- 0192US5756763APyrrolidine derivativesZAIDAN HOJIN BISEIBUTSU·Filed 1994·Granted May 26, 1998·46 cites·11 claims
- 0290US5965556APyrrolidine derivativesZAIDAN HOJIN BISEIBUTSU·Filed 1998·Granted Oct 12, 1999·46 cites·16 claims
- 0388US11302088B2Augmented reality display device and programSQUARE ENIX CO LTD·Filed 2021·Granted Apr 12, 2022·2 cites·8 claims
- 0487US5162500APoststatin and related compounds or salts thereofZAIDAN HOJIN BISEIBUTSU·Filed 1990·Granted Nov 10, 1992·31 cites·4 claims
- 0586US5359138APoststatin and related compounds or salts thereofZAIDAN HOJIN BISEIBUTSU·Filed 1992·Granted Oct 25, 1994·70 cites·3 claims
- 0665US9561235B2Preventive or therapeutic agent for pain associated with herpes zoster in acute phaseUNIV KYUSHU·Filed 2015·Granted Feb 7, 2017·1 cites·5 claims
- 0765US5221752Aα-keto amide derivativesNIPPON KAYAKU KK·Filed 1991·Granted Jun 22, 1993·19 cites·3 claims
- 0859US9115123B2Preventive or therapeutic agent for pain associated with herpes zoster in acute phaseINOUE KAZUHIDE·Filed 2011·Granted Aug 25, 2015·1 cites·5 claims
- 0957US11568608B2Augmented reality display device and program recording mediumSQUARE ENIX CO LTD·Filed 2021·Granted Jan 31, 2023·0 cites·6 claims
- 1053US2010256123A1P2x4 receptor antagonistNIPPON CHEMIPHAR CO·Filed 2007·Application pending·0 cites
- 1152US12070689B2Non-transitory computer readable medium including object linking program and object linking systemSQUARE ENIX CO LTD·Filed 2022·Granted Aug 27, 2024·0 cites·9 claims
- 1252US11983829B2Non-transitory computer readable medium including augmented reality processing program and augmented reality processing systemSQUARE ENIX CO LTD·Filed 2022·Granted May 14, 2024·0 cites·13 claims
- 1351US2021358262A1Medium, server device, and methodSQUARE ENIX CO LTD·Filed 2021·Application pending·0 cites
- 1451US2023214851A1Inspection program and inspection systemSQUARE ENIX CO LTD·Filed 2023·Application pending·0 cites
- 1550US11941763B2Viewing system, model creation apparatus, and control methodSQUARE ENIX CO LTD·Filed 2020·Granted Mar 26, 2024·0 cites·18 claims
- 1647US2011092703A1P2x4 receptor antagonistNIPPON CHEMIPHAR CO·Filed 2008·Application pending·0 cites
- 1746US2022261874A1Non-transitory computer readable medium storing event provision program and event provision systemSQUARE ENIX CO LTD·Filed 2022·Application pending·0 cites
- 1845US2022394194A1Computer-readable recording medium, computer apparatus, and control methodSQUARE ENIX CO LTD·Filed 2022·Application pending·0 cites
- 1944US2012116073A1P2x4 receptor antagonistSAKUMA SHOGO·Filed 2012·Application pending·0 cites
- 2042US2022245716A1Non-transitory computer readable medium storing virtual store management program and virtual store management systemSQUARE ENIX CO LTD·Filed 2022·Application pending·0 cites
- 2141US2005074819A1Screening method of drug for treatment of neuropathic painJAPAN HEALTH SCIENCE FOUND·Filed 2003·Application pending·0 cites
- 2239US4730076AProcess for producing α-aspartyl-phenylalanine esterNIPPON KAYAKU KK·Filed 1986·Granted Mar 8, 1988·5 cites·11 claims
- 2330US6433174B1Process for producing novel naphthyridine derivativesNIPPON KAYAKU KK·Filed 1999·Granted Aug 13, 2002·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →